MedGenome, a genomics-driven research and diagnostics company, on Tuesday organised a medical education session — ‘Inherited risk for breast & ovarian cancer’ — in association with Aasha Cancer Hospital in Mumbai.
This event was attended by 100 of the city’s leading consultants and specialists from the field of obstetrics, gynaecology, and general surgery along with patients, a statement said.
Speaking on the occasion, MedGenome’s scientific affairs team highlighted the risk of inheriting breast and ovarian cancer, the importance of genetic testing to identify an individual for breast or ovarian cancer risk, testing for BRCA1/2 gene mutation analysis, benefits and limitations of genetic testing and screening and cancer management for an individual who has a BRCA1/2 gene mutation.
Dr Satish Kamat, Cancer specialist and surgeon, who attended the conference, said, “Genetic testing is the future of the diagnostic industry. It provides us genomic information which helps in managing health care. MedGenome is the only lab having theadvanced facilities to perform genetic tests.”